Takeda’s R&D Life Science Day 2023 will include up to 5 meeting slots in Vienna for informal exchange of non-confidential knowledge.
Who is invited to participate?
Takeda’s R&D Science Day 2023 focuses on start-ups, SMEs, and application-oriented academic researchers in either life sciences or technology sphere. Takeda is particularly interested in sustainable process development technologies and analytical methods related to biologics and gene therapy. Such solutions should allow for sustainable lab practices and minimize the lifecycle environmental impact of new products from the development stage, through to manufacturing and over to packaging. Technologies can range from prototype and proof-of-concept stages to ready-to-use.
Please note that this is not a call for investment opportunities or strategic partnerships in early-stage drug development.
How to participate?
We ask you to submit non-confidential information in the form of 3-5 slides as well as 3-5 questions you would like to discuss with Takeda’s experts. For questions about participating, feel free to contact . This also is the e-mail address for sending your application to participate in the Takeda R&D Science Day.
Mark your calendar:
- March 17, 2023: Extended submission deadline for your files to Takeda
- April 19, 2023: Takeda R&D Life Science Day with individual meeting slots in Vienna
About Takeda in Austria
In Austria, Takeda works along the entire pharmaceutical value chain: Research & Development, Plasma Sourcing, Manufacturing and Patient Access. Takeda is Austria's largest pharmaceutical employer. Every day, more than 4,500 employees contribute to ensuring that medicines from Austria are delivered to patients in more than 100 countries worldwide and that patients in Austria have access to innovative medicines from Takeda. Takeda's development and production sites are in Vienna, Linz and Orth an der Donau. Takeda's Austrian product portfolio helps patients in areas such as oncology, hemophilia and genetic diseases, gastroenterology, and immunology. In R&D, Takeda’s activities in Austria cover the entire pharmaceutical development process from the selection of a product candidate over the monitoring of clinical trials up to the market release of the product. R&D Austria is a central player in Takeda’s global R&D engine. Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover, produce, and deliver life-transforming treatments for patients with rare and complex diseases worldwide and guided by the commitment to patients, our people and the planet.
www.takeda.at
Contact
Larissa Kahr
Head External Partnership Interface Europe
Pharmaceutical Sciences, R&D
Takeda Pharmaceuticals
Donau-City-Strasse 7
1220 Vienna, Austria
Elvira Kainersdorfer
Technology expert biotech & pharma
LISAvienna
Walcherstrasse 11A
1020 Vienna, Austria